Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
18-1
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.9
advertisement
11.9 Gene therapy
(12)
Showing records 1 to 12
Display all abstracts in classification
11.9 Gene therapy
Search within classification 11.9 Gene therapy
69435
Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells
Langouet-Astrie CJ
Experimental Eye Research
2016; 151: 61-67
69436
The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy
Foldvari M
Neural Regeneration Research
2016; 11: 875-877
69368
Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation
Miyake K
Molecular Vision
2016; 22: 816-826
69436
The intricacies of neurotrophic factor therapy for retinal ganglion cell rescue in glaucoma: a case for gene therapy
Chen DW
Neural Regeneration Research
2016; 11: 875-877
69435
Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells
Yang Z; Polisetti SM
Experimental Eye Research
2016; 151: 61-67
69368
Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation
Kobayashi M
Molecular Vision
2016; 22: 816-826
69435
Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells
Welsbie DS
Experimental Eye Research
2016; 151: 61-67
69368
Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation
Kameya S; Fujimoto C
Molecular Vision
2016; 22: 816-826
69435
Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells
Hauswirth WW; Zack DJ
Experimental Eye Research
2016; 151: 61-67
69368
Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation
Nakamoto K
Molecular Vision
2016; 22: 816-826
69435
Characterization of intravitreally delivered capsid mutant AAV2-Cre vector to induce tissue-specific mutations in murine retinal ganglion cells
Merbs SL; Enke RA
Experimental Eye Research
2016; 151: 61-67
69368
Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation
Igarashi T; Miyake N; Iijima O; Hirai Y; Shimada T; Okada T; Takahashi H
Molecular Vision
2016; 22: 816-826
Issue
18-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-2 (2024)
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement